Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis.

Cook EK, Izukawa T, Young S, Rosen G, Jamali M, Zhang L, Johnson D, Bain E, Hilland J, Ferrone CK, Buckstein J, Francis J, Momtaz B, McNaughton AJM, Liu X, Snetsinger B, Buckstein R, Rauh MJ.

Blood Adv. 2019 Aug 27;3(16):2482-2486. doi: 10.1182/bloodadvances.2018024729. No abstract available.

2.

Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.

Lassman AB, Aldape KD, Ansell PJ, Bain E, Curran WJ, Eoli M, French PJ, Kinoshita M, Looman J, Mehta M, Muragaki Y, Narita Y, Ocampo C, Roberts-Rapp L, Song M, Vogelbaum MA, Walenkamp AME, Wang TJC, Zhang P, van den Bent MJ.

J Neurooncol. 2019 Aug;144(1):205-210. doi: 10.1007/s11060-019-03222-y. Epub 2019 Jul 4.

PMID:
31273577
3.

Fate plasticity and reprogramming in genetically distinct populations of Danio leucophores.

Lewis VM, Saunders LM, Larson TA, Bain EJ, Sturiale SL, Gur D, Chowdhury S, Flynn JD, Allen MC, Deheyn DD, Lee JC, Simon JA, Lippincott-Schwartz J, Raible DW, Parichy DM.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11806-11811. doi: 10.1073/pnas.1901021116. Epub 2019 May 28.

4.

Defining EGFR amplification status for clinical trial inclusion.

French PJ, Eoli M, Sepulveda JM, de Heer I, Kros JM, Walenkamp A, Frenel JS, Franceschi E, Clement PM, Weller M, Ansell P, Looman J, Bain E, Morfouace M, Gorlia T, van den Bent M.

Neuro Oncol. 2019 Oct 9;21(10):1263-1272. doi: 10.1093/neuonc/noz096.

PMID:
31125418
5.

An Integrated Population Pharmacokinetic Model Versus Individual Models of Depatuxizumab Mafodotin, an Anti-EGFR Antibody Drug Conjugate, in Patients With Solid Tumors Likely to Overexpress EGFR.

Mittapalli RK, Stodtmann S, Friedel A, Menon RM, Bain E, Mensing S, Xiong H.

J Clin Pharmacol. 2019 Sep;59(9):1225-1235. doi: 10.1002/jcph.1418. Epub 2019 Apr 16.

PMID:
30990907
6.

Evolution of Endothelin signaling and diversification of adult pigment pattern in Danio fishes.

Spiewak JE, Bain EJ, Liu J, Kou K, Sturiale SL, Patterson LB, Diba P, Eisen JS, Braasch I, Ganz J, Parichy DM.

PLoS Genet. 2018 Sep 18;14(9):e1007538. doi: 10.1371/journal.pgen.1007538. eCollection 2018 Sep.

7.

Mechanics and nanovoid nucleation dynamics: effects of polar functionality in glassy polymer networks.

Elder RM, Long TR, Bain ED, Lenhart JL, Sirk TW.

Soft Matter. 2018 Nov 14;14(44):8895-8911. doi: 10.1039/c8sm01483c.

PMID:
30209509
8.

Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.

Lassman AB, van den Bent MJ, Gan HK, Reardon DA, Kumthekar P, Butowski N, Lwin Z, Mikkelsen T, Nabors LB, Papadopoulos KP, Penas-Prado M, Simes J, Wheeler H, Walbert T, Scott AM, Gomez E, Lee HJ, Roberts-Rapp L, Xiong H, Ansell PJ, Bain E, Holen KD, Maag D, Merrell R.

Neuro Oncol. 2019 Jan 1;21(1):106-114. doi: 10.1093/neuonc/noy091.

9.

Drowning in epilepsy: A population-based case series.

Bain E, Keller AE, Jordan H, Robyn W, Pollanen MS, Williams AS, Donner EJ.

Epilepsy Res. 2018 Sep;145:123-126. doi: 10.1016/j.eplepsyres.2018.06.010. Epub 2018 Jun 20.

PMID:
29957568
10.

Influence of molecular weight between crosslinks on the mechanical properties of polymers formed via ring-opening metathesis.

Long TR, Elder RM, Bain ED, Masser KA, Sirk TW, Yu JH, Knorr DB, Lenhart JL.

Soft Matter. 2018 May 2;14(17):3344-3360. doi: 10.1039/c7sm02407j.

PMID:
29658546
11.

Mechanical properties of silicone based composites as a temperature insensitive ballistic backing material for quantifying back face deformation.

Edwards TD, Bain ED, Cole ST, Freeney RM, Halls VA, Ivancik J, Lenhart JL, Napadensky E, Yu JH, Zheng JQ, Mrozek RA.

Forensic Sci Int. 2018 Apr;285:1-12. doi: 10.1016/j.forsciint.2018.01.014. Epub 2018 Jan 31.

PMID:
29426024
12.

Carbon nanofiber-filled conductive silicone elastomers as soft, dry bioelectronic interfaces.

Slipher GA, Hairston WD, Bradford JC, Bain ED, Mrozek RA.

PLoS One. 2018 Feb 6;13(2):e0189415. doi: 10.1371/journal.pone.0189415. eCollection 2018.

13.

Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study.

van den Bent M, Gan HK, Lassman AB, Kumthekar P, Merrell R, Butowski N, Lwin Z, Mikkelsen T, Nabors LB, Papadopoulos KP, Penas-Prado M, Simes J, Wheeler H, Walbert T, Scott AM, Gomez E, Lee HJ, Roberts-Rapp L, Xiong H, Bain E, Ansell PJ, Holen KD, Maag D, Reardon DA.

Cancer Chemother Pharmacol. 2017 Dec;80(6):1209-1217. doi: 10.1007/s00280-017-3451-1. Epub 2017 Oct 26.

14.
15.

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia.

Bain EE, Shafner L, Walling DP, Othman AA, Chuang-Stein C, Hinkle J, Hanina A.

JMIR Mhealth Uhealth. 2017 Feb 21;5(2):e18. doi: 10.2196/mhealth.7030.

16.

The American Cancer Society's Cancer Prevention Study 3 (CPS-3): Recruitment, study design, and baseline characteristics.

Patel AV, Jacobs EJ, Dudas DM, Briggs PJ, Lichtman CJ, Bain EB, Stevens VL, McCullough ML, Teras LR, Campbell PT, Gaudet MM, Kirkland EG, Rittase MH, Joiner N, Diver WR, Hildebrand JS, Yaw NC, Gapstur SM.

Cancer. 2017 Jun 1;123(11):2014-2024. doi: 10.1002/cncr.30561. Epub 2017 Feb 7.

17.

Change in public support for the introduction of plain packaging and new, enlarged graphic health warnings in the Australian state of Victoria, 2011-2013.

Hayes L, Wakefield MA, Bain E.

Tob Control. 2017 Nov;26(6):627-628. doi: 10.1136/tobaccocontrol-2016-053238. Epub 2016 Oct 17. No abstract available.

PMID:
27754923
18.

Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies.

Foroutan F, Guyatt GH, O'Brien K, Bain E, Stein M, Bhagra S, Sit D, Kamran R, Chang Y, Devji T, Mir H, Manja V, Schofield T, Siemieniuk RA, Agoritsas T, Bagur R, Otto CM, Vandvik PO.

BMJ. 2016 Sep 28;354:i5065. doi: 10.1136/bmj.i5065.

19.

Public health policy in a time of change and disaster in South Africa: 1910-1920.

Bain EG, Venter J.

Jamba. 2016 Sep 29;8(1):215. doi: 10.4102/jamba.v8i1.215. eCollection 2016.

20.

A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia.

Haig GM, Bain EE, Robieson WZ, Baker JD, Othman AA.

Am J Psychiatry. 2016 Aug 1;173(8):827-35. doi: 10.1176/appi.ajp.2015.15010093. Epub 2016 Mar 4.

PMID:
26940805
21.

Progressing towards standard outcomes in gestational diabetes Cochrane reviews and randomised trials.

Bain E, Middleton P, Crowther CA.

Aust N Z J Obstet Gynaecol. 2016 Feb;56(1):113-6. doi: 10.1111/ajo.12433. Epub 2016 Jan 12.

PMID:
26757351
22.

Long-distance communication by specialized cellular projections during pigment pattern development and evolution.

Eom DS, Bain EJ, Patterson LB, Grout ME, Parichy DM.

Elife. 2015 Dec 23;4. pii: e12401. doi: 10.7554/eLife.12401.

23.

Mitigating the Effects of Nonadherence in Clinical Trials.

Shiovitz TM, Bain EE, McCann DJ, Skolnick P, Laughren T, Hanina A, Burch D.

J Clin Pharmacol. 2016 Sep;56(9):1151-64. doi: 10.1002/jcph.689. Epub 2016 Jan 22.

24.

Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health.

Spencer L, Bubner T, Bain E, Middleton P.

Cochrane Database Syst Rev. 2015 Sep 21;(9):CD011263. doi: 10.1002/14651858.CD011263.pub2. Review.

PMID:
26387772
25.

Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework.

Bain E, Bubner T, Ashwood P, Van Ryswyk E, Simmonds L, Reid S, Middleton P, Crowther CA.

BMC Pregnancy Childbirth. 2015 Aug 18;15:176. doi: 10.1186/s12884-015-0618-9.

26.

Nonreceipt of antenatal magnesium sulphate for fetal neuroprotection at the Women's and Children's Hospital, Adelaide 2010-2013.

Siwicki K, Bain E, Bubner T, Ashwood P, Middleton P, Crowther CA.

Aust N Z J Obstet Gynaecol. 2015 Jun;55(3):233-8. doi: 10.1111/ajo.12334.

PMID:
26084194
27.

Repair of adjacent ocular defects.

Bain EE 3rd, Carucci J.

Dermatol Surg. 2015 Jun;41(6):741-3. doi: 10.1097/DSS.0000000000000325. No abstract available.

PMID:
25973560
28.

Diet and exercise interventions for preventing gestational diabetes mellitus.

Bain E, Crane M, Tieu J, Han S, Crowther CA, Middleton P.

Cochrane Database Syst Rev. 2015 Apr 12;(4):CD010443. doi: 10.1002/14651858.CD010443.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Nov 13;11:CD010443.

PMID:
25864059
29.

Lobular-appearing nodule on the scalp.

Bain EE 3rd, Hoffman M, Rothman IL.

Cutis. 2015 Jan;95(1):E17-9. No abstract available.

PMID:
25671452
30.

Creatine for women in pregnancy for neuroprotection of the fetus.

Dickinson H, Bain E, Wilkinson D, Middleton P, Crowther CA, Walker DW.

Cochrane Database Syst Rev. 2014 Dec 19;(12):CD010846. doi: 10.1002/14651858.CD010846.pub2. Review.

PMID:
25523279
31.

The incidence of DNR documentation in patients referred for palliative radiotherapy in the Rapid Response Radiotherapy Program.

Pulenzas N, Lechner B, Zhang L, Thavarajah N, Wong E, Lauzon N, Holden L, Sheehan P, Bedard G, McDonald R, Bain E, Tsao M, Barnes E, Danjoux C, Chow E.

J Palliat Med. 2014 Dec;17(12):1296-7. doi: 10.1089/jpm.2014.0322. No abstract available.

PMID:
25383944
32.
33.

9 tips to help prevent derm biopsy mistakes.

Miedema J, Zedek DC, Rayala BZ, Bain EE 3rd.

J Fam Pract. 2014 Oct;63(10):559-64.

PMID:
25343153
34.

Interventions for managing asthma in pregnancy.

Bain E, Pierides KL, Clifton VL, Hodyl NA, Stark MJ, Crowther CA, Middleton P.

Cochrane Database Syst Rev. 2014 Oct 21;(10):CD010660. doi: 10.1002/14651858.CD010660.pub2. Review.

35.

Thyroid hormone-dependent adult pigment cell lineage and pattern in zebrafish.

McMenamin SK, Bain EJ, McCann AE, Patterson LB, Eom DS, Waller ZP, Hamill JC, Kuhlman JA, Eisen JS, Parichy DM.

Science. 2014 Sep 12;345(6202):1358-61. doi: 10.1126/science.1256251. Epub 2014 Aug 28.

36.

Solitary necrobiotic xanthogranuloma of an upper extremity in association with multiple myeloma.

Bain EE 3rd, Meehan SA, Hale EK.

J Drugs Dermatol. 2014 May;13(5):598-600.

PMID:
24809886
37.

Magnesium supplementation in pregnancy.

Makrides M, Crosby DD, Bain E, Crowther CA.

Cochrane Database Syst Rev. 2014 Apr 3;(4):CD000937. doi: 10.1002/14651858.CD000937.pub2. Review.

38.

Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.

Bain E, Wilson A, Tooher R, Gates S, Davis LJ, Middleton P.

Cochrane Database Syst Rev. 2014 Feb 11;(2):CD001689. doi: 10.1002/14651858.CD001689.pub3. Review.

PMID:
24519568
39.

A randomized trial of the efficacy and safety of the H3 antagonist ABT-288 in cognitive impairment associated with schizophrenia.

Haig GM, Bain E, Robieson W, Othman AA, Baker J, Lenz RA.

Schizophr Bull. 2014 Nov;40(6):1433-42. doi: 10.1093/schbul/sbt240. Epub 2014 Feb 10.

40.

Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial.

Bain ES, Middleton PF, Yelland LN, Ashwood PJ, Crowther CA.

BJOG. 2014 Apr;121(5):595-603. doi: 10.1111/1471-0528.12535. Epub 2014 Jan 6.

41.

Working to improve survival and health for babies born very preterm: the WISH project protocol.

Crowther CA, Middleton PF, Bain E, Ashwood P, Bubner T, Flenady V, Morris J, McIntyre S; WISH Project Team.

BMC Pregnancy Childbirth. 2013 Dec 19;13:239. doi: 10.1186/1471-2393-13-239.

42.

Drug-drug interaction between methotrexate and levetiracetam resulting in delayed methotrexate elimination.

Bain E, Birhiray RE, Reeves DJ.

Ann Pharmacother. 2014 Feb;48(2):292-6. doi: 10.1177/1060028013511951. Epub 2013 Nov 18.

PMID:
24259648
43.

Mediator subunit 12 coordinates intrinsic and extrinsic control of epithalamic development.

Wu SY, de Borsetti NH, Bain EJ, Bulow CR, Gamse JT.

Dev Biol. 2014 Jan 1;385(1):13-22. doi: 10.1016/j.ydbio.2013.10.023. Epub 2013 Oct 30.

44.

Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour.

Naik Gaunekar N, Raman P, Bain E, Crowther CA.

Cochrane Database Syst Rev. 2013 Oct 31;(10):CD004071. doi: 10.1002/14651858.CD004071.pub3. Review.

PMID:
24173691
45.

Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review.

Bain ES, Middleton PF, Crowther CA.

BMC Pregnancy Childbirth. 2013 Oct 21;13:195. doi: 10.1186/1471-2393-13-195. Review.

46.

Analgesia for forceps delivery.

Nikpoor P, Bain E.

Cochrane Database Syst Rev. 2013 Sep 30;9:CD008878. [Epub ahead of print]

PMID:
24085633
47.

Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth.

Brownfoot FC, Gagliardi DI, Bain E, Middleton P, Crowther CA.

Cochrane Database Syst Rev. 2013 Aug 29;(8):CD006764. doi: 10.1002/14651858.CD006764.pub3. Review.

PMID:
23990333
48.

Relaxin for preventing preterm birth.

Bain E, Heatley E, Hsu K, Crowther CA.

Cochrane Database Syst Rev. 2013 Aug 16;(8):CD010073. doi: 10.1002/14651858.CD010073.pub2. Review.

PMID:
23949874
49.

Magnesium sulphate for the prevention of cerebral palsy in Australia and New Zealand.

Bain E, Goodchild L, Lontis R, McIntyre S, Ashwood P, Bubner T, Middleton P, Crowther C.

Aust Nurs J. 2013 Jul;21(1):34-7. No abstract available.

PMID:
23930314
50.

Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression.

Nugent AC, Carlson PJ, Bain EE, Eckelman W, Herscovitch P, Manji H, Zarate CA Jr, Drevets WC.

J Psychopharmacol. 2013 Oct;27(10):894-902. doi: 10.1177/0269881113499204. Epub 2013 Aug 7.

Supplemental Content

Support Center